Matthew Todd

See the following -

Announcing the Recipients For The Accelerating Science Award Program

David Knutson | PLOS.org | October 21, 2013

The three award recipients for the Accelerating Science Award Program (ASAP)  were announced today in Washington, DC at the Open Access Week kickoff event hosted by the Scholarly Publishing and Academic Resources Coalition (SPARC) and the World Bank. Read More »

Australian High School Students Use Open Source to Make Shkreli's $750 Drug For Less Than $2

Press Release | University of Sydney | November 30, 2016

Sydney Grammar students, under the supervision of the University of Sydney and global members of the Open Source Malaria consortium, have reproduced an essential medicine in their high school laboratories. The drug, Daraprim, had been the subject of controversy when the price was hiked from US$13.50 to US$750 a dose last year. Daraprim - originally used as an antimalarial after its synthesis by Nobel Prize winner Gertrude Elion - is now more widely used as an anti-parasitic treatment for toxoplasmosis, which can be a dangerous disease for pregnant women and people with compromised immune systems, such as those living with HIV or AIDS...

Read More »

Australian Students Recreate Martin Shkreli Price-Hike Drug in School lab

Play VideoPlay Current Time 0:00 / Duration Time 0:49 Loaded: 0% Progress: 0% FullscreenMute Sydney students recreate life-saving drug that had 5,000% price hike Melissa Davey | The Guardian | November 30, 2016

A group of Australian high school students have managed to recreate a life-saving drug that rose from US$13.50 to US$750 a tablet overnight after an unscrupulous price-hike by former hedge fund manager Martin Shkreli. The Sydney Grammar students reproduced the drug, Daraprim, used to treat a rare but deadly parasitic infection, in their high school laboratory with support from the University of Sydney and global members of the Open Source Malaria consortium...

Read More »

Breaking Good: School Students Make Costly Drug Cheaply Using Open Source Approach

Press Release | University of Sydney | November 30, 2016

Sydney Grammar students, under the supervision of the University of Sydney and global members of the Open Source Malaria consortium, have reproduced an essential medicine in their high school laboratories. The drug, Daraprim, had been the subject of controversy when the price was hiked from US $13.50 to US$750 a dose last year. Daraprim - originally used as an antimalarial after its synthesis by Nobel Prize winner Gertrude Elion - is now more widely used as an anti-parasitic treatment for toxoplasmosis, which can be a dangerous disease for pregnant women and people with compromised immune systems, such as those living with HIV or AIDS...

Read More »

International Team of Scientists Open Sources Search for Malaria Cure

The Open Source Malaria (OSM) project operates along very similar lines to traditional medicinal chemistry projects in that the team is looking for an antimalarial drug candidate suitable for Phase 1 clinical trials. However, the day to day running of the project works quite differently and is probably most clearly defined by the team’s commitment to The Six Laws of Open Science... Read More »

Open Access Award Recipients Announced

Staff Writer | Wellcome Trust | October 22, 2013

To mark the beginning of Open Access Week, the Accelerating Science Award Programme announced the three recipients of its inaugural award yesterday in Washington, DC. Read More »

Open Access Week 2013: A Recap Of This Year’s Global Celebration

Abby Clobridge | Information Today | October 31, 2013

This year’s Open Access Week, a global event that just finished its sixth year, was held Oct. 21–27, 2013. Celebrations of various types were sponsored by libraries, students, researchers, publishers, and nonprofit organizations to increase awareness about open access (OA). [...] Read More »

Open Source Malaria Project Head Wins Accelerating Science Award

Belinda Smith | The Conversation | October 22, 2013

Dr Matthew Todd – leader of the Open Source Malaria consortium in Sydney, senior lecturer at the University of Sydney and Conversation author – was awarded one of three Accelerating Science Awards in Washington DC yesterday. Read More »

Open Source Malaria Research Paves Way for Inexpensive Medicines

Press Release | University of Sydney | September 14, 2016

A real-time drug discovery project involving some 50 researchers in nine countries has shown open source malaria research works - providing a potential alternative for medicines similar to the way in which open source products compete with proprietary products in software. Malaria is one of the leading causes of mortality in developing countries – last year killing more than 400,000 people. Researchers worldwide have found the solution for drug discovery could lie in open, “crowd-sourced” science...

Read More »

Tata Trusts support the creation of the Open Source Pharma Foundation

Press Release | Tata Trusts, Open Source Pharma Foundation | September 29, 2015

Seeking to create a world of affordable medicine for all, Tata Trusts has announced their support for the creation of the Open Source Pharma Foundation (OSPF) at OSP2, the 2nd Annual Global Open Source Pharma conference. Held at Castle Rauischholzhausen in Germany on Sept 01 to 03, 2015, the OSP conference brought together researchers, NGOs, industry professionals, philanthropists and entrepreneurs...Open Source Pharma (OSP) is a concept inspired by the Linux model of operation. Adapted to tackling important public health challenges, it hopes to catalyze radical change in the way we do medical R&D and deliver better and more affordable innovation quicker and cheaper to patients.

Read More »